Quoin Pharmaceuticals, Ltd.
Recent Filings
All 540 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 26, 2026 |
| 8-K | FORM 8-K | Mar 26, 2026 |
| 8-K | FORM 8-K | Mar 11, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 11, 2026 |
| SCHEDULE 13G/A | — | Feb 6, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 6, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 6, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 6, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| LANGER DENNIS | — | Purchase | 15,152 @ $8.49 | 15,153 | Oct 14, 2025 |
| Carter Denise P. | Chief Operating Officer | Purchase | 555,556 @ $0.45 | 602,648 | Dec 23, 2024 |
| Myers Michael | Chief Executive Officer | Purchase | 555,556 @ $0.45 | 602,808 | Dec 23, 2024 |
| Dunn Gordon | Chief Financial Officer | Purchase | 122,221 @ $0.45 | 151,077 | Dec 23, 2024 |
| Culverwell Anthony James | — | Purchase | 100,000 @ $0.45 | 100,317 | Dec 23, 2024 |
| Dunn Gordon | Chief Financial Officer | Purchase | 10,000 @ $0.71 | 28,856 | Sep 10, 2024 |
| Myers Michael | Chief Executive Officer | Purchase | 8,200 @ $0.75 | 23,680 | Sep 4, 2024 |
| Carter Denise P. | Chief Operating Officer | Purchase | 22,988 @ $0.80 | 47,092 | Sep 3, 2024 |
| LANGER DENNIS | — | Sale | 297 @ $0.73 | 53 | Jun 7, 2024 |